Internal Medicine, Endocrinology, Diabetes, & Metabolism · Phoenix, AZ
NPI
1023230778
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
10030 N 25th Ave Ste 200
Phoenix, AZ, 85021
Phone (602) 726-8805
Groups this clinician bills Medicare through
Medicare paid, 2024
$123K
6,841 services
Medicare patients, 2024
297
Average age 74
Drug cost, 2024
$1.6M
3,740 prescriptions
Company payments, 2025
$80.44
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Allison M Peckumn was code J0897 (injection, denosumab, 1 mg), 3,300 times for 34 patients. In total Allison M Peckumn billed 6,841 services in 12 codes, and Medicare paid $123K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,300 | 34 | $20.59 | $68K |
| 99214 Office E&M - Established | Office | 440 | 270 | $88.21 | $39K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 377 | 240 | $11.63 | $4,384 |
| 95251 Test - Miscellaneous | Office | 79 | 41 | $26.55 | $2,098 |
| 96372 Injection Administration | Office | 70 | 37 | $10.48 | $734 |
| 99215 Office E&M - Established | Office | 54 | 40 | $124.30 | $6,712 |
| 99204 Office E&M - New | Office | 16 | 16 | $119.28 | $1,908 |
By year: 2022 $111K for 9,755 services; 2023 $105K for 6,199 services; 2024 $123K for 6,841 services.
Medicare prescription drug claims, 2024
In 2024, the drug Allison M Peckumn prescribed most often to Medicare patients was Levothyroxine Sodium, with 555 prescriptions and refills. In total Allison M Peckumn wrote 3,740 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 555 | 1,539 | 169 | $5,356 |
| Ozempic Semaglutide | 273 | 466 | 67 | $438K |
| Metformin Hcl Generic | 169 | 471 | 59 | $1,409 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 133 | 281 | 51 | $21K |
| Trulicity Dulaglutide | 130 | 225 | 37 | $225K |
| Synthroid Levothyroxine Sodium | 112 | 291 | 34 | $11K |
| Jardiance Empagliflozin | 106 | 255 | 31 | $148K |
| Metformin Hcl Er Metformin Hcl | 105 | 312 | 39 | $1,360 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 89 | 220 | 34 | $13K |
| Atorvastatin Calcium Generic | 81 | 218 | 31 | $638 |
| Tresiba Flextouch U-200 Insulin Degludec | 77 | 153 | 21 | $116K |
| Lisinopril Generic | 74 | 200 | 23 | $410 |
| Glipizide Er Glipizide | 74 | 213 | 22 | $1,201 |
| Glimepiride Generic | 71 | 215 | 22 | $488 |
| Glipizide Generic | 67 | 166 | 23 | $395 |
Brand drugs: 1,814 claims; generic drugs: 1,599 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Allison M Peckumn $80.44 ($80.44 in general payments such as food, travel and fees) from 4 companies. The largest payer was Sequel Med Tech, LLC with $30.39.
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 1 | $30.39 |
| Ascensia Diabetes Care Us Inc. | 1 | $21.02 |
| Abbott Laboratories ABT | 1 | $17.57 |
| 3B Medical, Inc. | 1 | $11.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.